Puma Biotechnology Stock Price. Everything You Need To Know About The Puma Biotechnology Stock!
Puma Biotechnology, Inc. is a biopharmaceutical company headquartered in Los Angeles, California, that is committed to enhancing cancer care. With a team of 192 full-time employees, Puma Biotechnology is focused on developing and commercializing products that can help treat HER2-positive breast cancer and HER2 mutated cancers.
The company’s lead product is NERLYNX, an oral version of neratinib, a potent irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the human epidermal growth factor receptors, HER1, HER2 and HER4. NERLYNX has clinical application in the treatment of several cancers that over-express or have a mutation in HER2 or epidermal growth factor receptor (EGFR), including breast cancer, cervical cancer, lung cancer, and other solid tumors.
Since going public in 2012, Puma Biotechnology has been primarily focused on developing and commercializing the oral version of neratinib, along with other advanced drug candidates aimed at treating various cancers. Its other products include PB272 (neratinib, intravenous), PB357, and certain related compounds.
Keeping track of the stock price of Puma Biotechnology, and its market cap, can provide insight into the company’s potential for growth and success in the pharmaceutical industry. For investors interested in the industry, researching Puma Biotechnology and its innovative cancer care products could prove beneficial in making informed investment decisions.
Puma Biotechnology Stock Price. Everything You Need To Know About The Puma Biotechnology Stock! performance
- Employees 192
- Company HQ Los Angeles
- Website https://www.pumabiotechnology.com/
- PBYI Asset Type Common Stock
- PBYI Market Capitalization 242M
- Earnings Per Share 0.45
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth -0.781
Looking to invest in Puma Biotechnology but unsure of how to proceed from Malaysia, Thailand, Indonesia, or Vietnam? Look no further! Here at Zorion, we provide retail investors from these countries with the essential investment insights and recommendations needed to confidently make investment decisions. Puma Biotechnology, a leading biopharmaceutical company, focuses on developing innovative cancer treatments. Investing in Puma Biotechnology can be a lucrative opportunity, considering its promising pipeline and potential for growth. To invest in Puma Biotechnology from Malaysia, Thailand, Indonesia, or Vietnam, simply sign up with Zorion and gain access to a plethora of resources and educational materials to further enhance your investment knowledge. Start your investment journey with Puma Biotechnology today and make informed decisions.
